Amneal Pharmaceuticals
AMRX
AMRX
167 hedge funds and large institutions have $2.41B invested in Amneal Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 57 increasing their positions, 48 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 35
1% more funds holding
Funds holding: 166 → 167 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
167
Holding in Top 10
1
Calls
$1.47M
Puts
$1.22M
Top Buyers
| 1 | +$245M | |
| 2 | +$46.5M | |
| 3 | +$44.5M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$34.1M |
| 5 |
HM
HealthCor Management
New York
|
+$23M |
Top Sellers
| 1 | -$45.7M | |
| 2 | -$34.4M | |
| 3 | -$24.6M | |
| 4 |
Fisher Asset Management
Camas,
Washington
|
-$24M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
-$16.5M |